Valiant Laboratories Share Price
Small Cap | Pharmaceuticals and health care | NSE: VALIANTLAB | BSE: 543998
₹80.65 
-2.21 (-2.67 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 92.95
High (₹) 92.95
Low (₹) 80.20
Prev. Close (₹) 82.86
Volume 3,773
VWAP (₹) 81.31
ROCE (%) -0.22
Industry P/E 43.95
TTM P/E -84.89
P/B Ratio 1.48
Market Cap (₹) Cr.350.99
Dividend Yield (%)--
EPS (₹) 0.13
ROE0.24%
Sales Growth (%) -45.48
Profit Growth (%)-98.90
Day Range
92.9592.95
52 Week Range
79.95171.15
Historical Returns
Returns (6M)
-37.21 %
Returns (1Y)
-44.91 %
Returns (3Y)
-52.29 %
Returns (5Y)
-52.29 %
Returns (6M)
-37.21 %
Returns (1Y)
-44.91 %
Returns (3Y)
-52.29 %
Returns (5Y)
-52.29 %
SWOT Analysis
- Company with Low Debt
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
BEARISHRSI 34.03
MFI 14.42
ATR 6.04
Commodity Channel Index -201.67
ROC125 -29.67
ROC21 -20.11
Williams %R -99.00
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 86.85 | 93.45 | 96.90 | 83.40 | 76.80 | 73.35 | 66.75 |
| Week Ago | 99.69 | 106.72 | 110.44 | 95.97 | 88.94 | 85.22 | 78.19 |
| Month Ago | 105.11 | 112.88 | 117.81 | 100.18 | 92.41 | 87.48 | 79.71 |
EMA & SMA
80.65
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 90.11
9 Day 92.88
10 Day 92.69
12 Day 94.69
14 Day 95.72
20 Day 97.27
26 Day 98.29
50 Day 104.61
100 Day 109.51
200 Day 120.97
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 19 Feb, 2025 | NSE India | Valiant Laboratories Limited has informed the Exchange about Credit Rating |
| 19 Feb, 2025 | BSE India | Announcement under Regulation 30 regarding Credit Ratings issued to the Company |
| 08 Feb, 2025 | NSE India | Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication |
| 07 Feb, 2025 | NSE India | Integrated Filing (Financials) Report for the quarter ended December 31, 2024 |
| 07 Feb, 2025 | BSE India | Integrated Filing (Financial) Report for the quarter ended December 31, 2024 |
| 07 Feb, 2025 | NSE India | Valiant Laboratories Limited has informed the Exchange about General Updates |
| 07 Feb, 2025 | BSE India | Authorised Persons for Determining/ Disclosing Material Events/ Information. |
| 07 Feb, 2025 | NSE India | Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024. |
| 07 Feb, 2025 | BSE India | Financial Results for the quarter ended December 31, 2024. |
| 07 Feb, 2025 | NSE India | Valiant Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 07, 2025. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 19 Feb, 2025 | 07 Feb, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 12 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 12 Aug, 2024 |
| Audited Results | -- | 08 May, 2024 | 14 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 09 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 06 Nov, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Valiant Laboratories
Valiant Laboratories is a Public Limited Listed company incorporated on 06/08/2021 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH2021PLC365904 and registration number is 365904. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 182.05 Cr. and Equity Capital is Rs. 43.45 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2021
Managing Director
Mr. Santosh S Vora
NSE Symbol
VALIANTLAB
Valiant Laboratories Management
| Name | Designation |
|---|---|
| Mr. Velji K Gogri | Chairman & Ind.Director |
| Mr. Santosh S Vora | Managing Director |
| Mr. Paresh S Shah | Executive Director |
| Mr. Shantilal S Vora | Non Executive Director |
| Mr. Sandeep N Gupta | Non Executive Director |
| Mrs. Sonal A Vira | Independent Director |
| Mr. Mulesh M Savla | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Valiant Laboratories
What is the share price of Valiant Laboratories?
The share price of Valiant Laboratories on 13 Mar, 2025 is ₹ 80.65.
What is 52W high and 52W low share price of Valiant Laboratories?
The highest and lowest 52W share prices of Valiant Laboratories are ₹ 171.150 and ₹ 79.950
What is the market cap of Valiant Laboratories?
The market capitalization of Valiant Laboratories as of 13 Mar, 2025 is ₹ 350.99 Crores
What is the P/E ratio of Valiant Laboratories?
The current P/E ratio of Valiant Laboratories as of 13 Mar, 2025 is 43.95
What is the PB ratio of Valiant Laboratories?
The PB ratio of Valiant Laboratories as of 13 Mar, 2025 is 1.48
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)